Repurposing
of marketed / shelved / pipeline candidates for the treatment of diseases
(different from original target indications) has emerged as a viable business
strategy. The rising popularity of this approach can further be attributed to
various benefits, such as reduced development timelines, decreased investments
and relatively higher success rates (considering that the safety profiles of
such candidates have already been established).
To order this 250+ page report, which features 100+ figures
and 140+ tables, please visit this https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
The
USD 1.2 billion (by 2030) financial opportunity within the drug repurposing
service providers market has been analyzed across the following segments:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
The Drug
Repurposing Service Providers Market, 2020-2030.” report
features the following companies, which we identified to be key players in this
domain:
§
§
§
§
§
§
§
§
§
§
§
§
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Role of Non-Profit / Academic Organizations
6. Company Profiles
7. Partnerships
8. Big Pharma Initiatives
9. Case Study: Discontinued Drug Development Programs
10. Cost Saving Analysis
11. Market Forecast and Opportunity Analysis
12. Covid-19 Impact on
Drug Repurposing Service Providers Market
13. Recent Advancements and Trends in Outsourcing of Drug
Repurposing
14. Interview Transcripts
15. Appendix 1: List of Potential Drug-Indication Candidates for
Drug Repurposing
16. Appendix 2: Tabulated Data
17. Appendix 3: List of Companies and Organizations
To
purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
Contact Details
Gaurav
Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
